

(Sharecast News) - The Mail on Sunday's Midas column recommended readers 'buy' shares of pharmacovigilance specialist Ergomed.


UK EARNINGS SUMMARY: Tremor Loss Widens, Expects Third-Quarter Profit


UK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec


UK Earnings, Trading Statements Calendar - Next 7 Days


(Sharecast News) - Specialised pharmaceutical services company Ergomed said on Tuesday that it had an "excellent" first half, with overall growth in r...


UK TRADING UPDATE SUMMARY: DP Eurasia Interim Sales Up On Turkey Rise


UK TRADING UPDATE SUMMARY: XLMedia To Sell Finnish Casino Assets


(Sharecast News) - Specialist pharmaceutical services company Ergomed said on Wednesday that it had a "good" first quarter, with "solid" overall growt...